Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Cardiovascular autonomic neuropathy in type 2 diabetic patients
Ikaro Soares Santos Breder1, Andrei C Sposito2
1Endocrinologist - Doctorate Student at the Laboratory of Vascular Biology and Atherosclerosis. -Faculty of medical Sciences (FCM) - State University of Campinas (Unicamp) - Campinas (SP) - Brasil.
Insights
Type 2 Diabetes Mellitus (T2DM) patients may develop cardiac autonomic neuropathy, increasing mortality. This review covers T2DM neuropathy concepts, diagnosis, and treatments, including new drugs with potential cardiac benefits.
Area of Science:
- Endocrinology
- Cardiology
- Diabetology
Background:
- Diabetes Mellitus is a prevalent chronic condition requiring multidisciplinary care.
- Type 2 Diabetes Mellitus (T2DM) is associated with cardiac autonomic neuropathy (CAN).
- CAN in T2DM significantly elevates mortality and morbidity risks.
Purpose of the Study:
- To review current understanding of T2DM-related cardiac autonomic neuropathy.
- To outline clinical features, diagnostic approaches, and prognostic factors.
- To discuss potential therapeutic strategies for T2DM-induced CAN.
Main Methods:
- Literature review of current concepts and research.
- Analysis of clinical features and diagnostic criteria for CAN in T2DM.
- Evaluation of treatment options, including novel pharmacotherapies.
Main Results:
- CAN is a serious complication of T2DM, impacting cardiovascular health.
- Early diagnosis and management are crucial for improving patient outcomes.
- Emerging glucose-lowering agents show promise beyond glycemic control, potentially reducing cardiovascular events.
Conclusions:
- Cardiac autonomic neuropathy is a critical concern in T2DM management.
- A comprehensive approach involving various specialists is essential.
- Novel pharmacological interventions may offer cardioprotective benefits in T2DM patients at risk.
Abstract:
Diabetes is one of the most common chronic pathologies around the world, involving treatment with general clinicians, endocrinologists, cardiologists, ophthalmologists, nephrologists and a multidisciplinary team. Patients with type 2 Diabetes Mellitus (T2DM) can be affected by cardiac autonomic neuropathy, leading to increased mortality and morbidity. In this review, we will present current concepts, clinical features, diagnosis, prognosis, and possible treatment. New drugs recently developed to reduce glycemic level presented a pleiotropic effect of reducing sudden death, suggesting a potential use in patients at risk.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Autonomic Nervous System
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Autonomic Nervous System: Overview

